In the Mix: 5 More Articles — March 13, 2026
This article reviews cannabis regulation business retail developments impacting the market and legal landscape. Key topics include workplace drug testing changes and dispensary expansion. Understanding these trends is essential for clinicians and…
IRS Files First Response to Common Industry 280E Arguments
The IRS Section 280E tax deductions cannabis policy directly impacts cannabis business profitability and patient access. This response clarifies tax burdens on cannabis businesses. Clinicians should understand these tax implications when advising…
In the Mix: 7 More Articles — March 12, 2026
This article reviews cannabis regulatory uncertainty and its clinical implications. It highlights tax disputes and illicit market challenges affecting patient access. Clinicians must navigate these complexities to ensure safe cannabis medicine.
9th Circuit Ruling Sparks Legal Uncertainty in Cannabis Commerce
The 9th Circuit ruling creates cannabis commerce legal uncertainty by exempting cannabis from the dormant commerce clause. This decision allows states to impose protectionist cannabis regulations. Clinicians must navigate fragmented state cannabis…
IRS Disputes Cannabis Company’s Tax Argument (Newsletter: March 12, 2026)
Cannabis companies tax disputes with the IRS create financial uncertainty that may affect product pricing and availability for patients who depend on medical cannabis. The ongoing tax disputes highlight federal barriers to cannabis industry legitimacy…
After Federal Court Win, Oklahoma Medical Marijuana Operators Fight State
Oklahoma medical marijuana legal challenges have intensified after a federal court victory for operators. These legal disputes focus on state regulatory overreach affecting patient access. Clinicians should monitor these developments as they impact the…
How Rescheduling Will Impact Cannabis Intellectual Property Valuations
Cannabis intellectual property valuation will significantly shift following federal rescheduling, reshaping medical cannabis operators' asset pricing. This change primarily impacts pharmaceutical-grade cannabis products developed under strict research…
How Federal Rescheduling Could Influence Tennessee Medical Cannabis Legalization
Tennessee medical cannabis legalization prospects are evolving with federal rescheduling discussions. This shift could allow clinicians to recommend cannabis legally, expanding treatment options. Tennessee healthcare providers should stay informed about…
Federal Law Bars Workers Compensation Coverage for Medical Marijuana Use
Federal workers compensation cannabis coverage is prohibited under federal law, despite state medical marijuana programs. Injured workers may face out-of-pocket costs for cannabis treatments. Clinicians should counsel patients on insurance limitations…
In the Mix: 9 More Articles — March 11, 2026
This article reviews cannabis market consolidation and clinical trends in 2026. It highlights regulatory developments and CBD products for pain management. Cannabis market consolidation is shaping clinical applications and governance.